Jennifer L. Stotka
Jennifer L. Stotka publishes mostly in Infectious Diseases, Epidemiology and Pharmacology, on topics such as Pharmaceutical industry and healthcare, Antibiotics Pharmacokinetics and Efficacy and Biomedical Ethics and Regulation.
- World rank
- #3,509,595 of 7,710,434 ranked researchers
- Rank in United States
- #981,292 of 1,627,098
- Works
- 20
- Citations
- 1.1k
- Citations per work
- 52.6
What does Jennifer L. Stotka research?
Jennifer L. Stotka's work is mostly in Medicine (42%), Pharmacology, Toxicology and Pharmaceutics (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1049.0%
- Health Sciences842.2%
- Medicine842.2%
- Life Sciences28.8%
- 1Infectious Diseases12% of their works
- 2Epidemiology10% of their works
- 3Pharmacology9% of their works
- 4Pharmacology9% of their works
- 5Physiology5% of their works
- 6Cardiology and Cardiovascular Medicine5% of their works
Research topics
- Pharmaceutical industry and healthcare
- Antibiotics Pharmacokinetics and Efficacy
- Biomedical Ethics and Regulation
- Pharmacogenetics and Drug Metabolism
- Pharmacovigilance and Adverse Drug Reactions
- Pneumonia and Respiratory Infections
- Clostridium difficile and Clostridium perfringens research
- Drug-Induced Adverse Reactions
Which keywords describe Jennifer L. Stotka's research?
The keywords of their largest research topics: Clinical Trials, Antimicrobial Resistance, Clinical Practice Guidelines, Epidemiology, Antibiotic Pharmacokinetics, Conflict of Interest, Critically Ill Patients and Pharmaceutical Industry.
- Stevens-Johnson Syndrome
- Pharmacovigilance
- HLA-B*5701
- Cytochrome P450
- Antibiotic-Associated Diarrhea
- Stem Cell Regulation
- Pharmaceutical Industry
- Conflict of Interest
- Epidemiology
- Antimicrobial Resistance
- Clinical Trials
- Clinical Practice Guidelines
- Antibiotic Pharmacokinetics
- Critically Ill Patients
- Regulatory Challenges
- Adverse Drug Reactions
- Community-Acquired Pneumonia
- Fecal Microbiota Transplantation
- Pharmacogenetics
- Pneumococcal Conjugate Vaccine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Clinical Trials62 topics
- Antimicrobial Resistance52 topics
- Clinical Practice Guidelines42 topics
- Epidemiology42 topics
- Antibiotic Pharmacokinetics31 topic
- Conflict of Interest31 topic
- Critically Ill Patients31 topic
- Pharmaceutical Industry31 topic
- Regulatory Challenges31 topic
- Stem Cell Regulation31 topic
- Adverse Drug Reactions21 topic
- Antibiotic-Associated Diarrhea21 topic
- Community-Acquired Pneumonia21 topic
- Cytochrome P45021 topic
- Fecal Microbiota Transplantation21 topic
- HLA-B*570121 topic
- Pharmacogenetics21 topic
- Pharmacovigilance21 topic
- Pneumococcal Conjugate Vaccine21 topic
- Stevens-Johnson Syndrome21 topic
Where does Jennifer L. Stotka work?
Jennifer L. Stotka's main affiliation in the publication record is Eli Lilly (United States), United States.
How many publications and citations does Jennifer L. Stotka have?
OpenAlex counts 20 works and 1,051 citations for Jennifer L. Stotka, an h-index of 11, ranking #3,509,595 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jennifer L. Stotka. Posts are plain text and can be reported.